Blue Sail Medical Co Ltd Net Assets

Latest as of March 2026: CN¥9.41 Billion CNY ≈ $1.38 Billion USD

Blue Sail Medical Co Ltd net assets. Based on the latest financial reports, Blue Sail Medical Co Ltd (002382) has net assets worth CN¥9.41 Billion CNY (≈ $1.38 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥16.12 Billion ≈ $2.36 Billion USD) and total liabilities (CN¥6.71 Billion ≈ $981.56 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See 002382 equity to assets ratio to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥9.41 Billion
% of Total Assets 58.38%
Annual Growth Rate 28.66%
5-Year Change -10.21%
10-Year Change 627.74%
Growth Volatility 120.09

Net Assets of Blue Sail Medical Co Ltd (2006–2025)

Net assets of Blue Sail Medical Co Ltd from 2006 to 2025. This chart illustrates how Blue Sail Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Blue Sail Medical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Annual Net Assets for Blue Sail Medical Co Ltd (2006–2025)

The table below shows the annual net assets of Blue Sail Medical Co Ltd from 2006 to 2025. For live market cap and overall valuation, see market cap of Blue Sail Medical Co Ltd.

Year Net Assets Change
2025-12-31 CN¥9.46 Billion
≈ $1.38 Billion
-3.47%
2024-12-31 CN¥9.80 Billion
≈ $1.43 Billion
+2.64%
2023-12-31 CN¥9.55 Billion
≈ $1.40 Billion
-9.51%
2022-12-31 CN¥10.55 Billion
≈ $1.54 Billion
+0.15%
2021-12-31 CN¥10.54 Billion
≈ $1.54 Billion
+7.32%
2020-12-31 CN¥9.82 Billion
≈ $1.44 Billion
+16.00%
2019-12-31 CN¥8.46 Billion
≈ $1.24 Billion
+8.51%
2018-12-31 CN¥7.80 Billion
≈ $1.14 Billion
+446.09%
2017-12-31 CN¥1.43 Billion
≈ $209.01 Million
+9.87%
2016-12-31 CN¥1.30 Billion
≈ $190.24 Million
+9.82%
2015-12-31 CN¥1.18 Billion
≈ $173.22 Million
+13.20%
2014-12-31 CN¥1.05 Billion
≈ $153.03 Million
+6.24%
2013-12-31 CN¥984.34 Million
≈ $144.04 Million
+2.34%
2012-12-31 CN¥961.83 Million
≈ $140.75 Million
+4.93%
2011-12-31 CN¥916.68 Million
≈ $134.14 Million
+1.43%
2010-12-31 CN¥903.72 Million
≈ $132.24 Million
+344.61%
2009-12-31 CN¥203.26 Million
≈ $29.74 Million
+28.31%
2008-12-31 CN¥158.41 Million
≈ $23.18 Million
+63.22%
2007-12-31 CN¥97.05 Million
≈ $14.20 Million
+23.15%
2006-12-31 CN¥78.81 Million
≈ $11.53 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Blue Sail Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1975.2% over the analyzed period, indicating profitable operations and earnings retention.

Blue Sail Medical Co Ltd Net Assets Breakdown (December 2025)

Blue Sail Medical Co Ltd net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings CN¥849.20 Million 11.85%
Other Components CN¥6.32 Billion 88.15%
Total Equity CN¥7.17 Billion 100.00%

Blue Sail Medical Co Ltd Competitors by Market Cap

The table below lists competitors of Blue Sail Medical Co Ltd ranked by their market capitalization.

Company Market Cap
Hiecise Precision Equipment Co Ltd
SHE:300809
$797.67 Million
B-Soft Co Ltd
SHE:300451
$797.93 Million
Aces Electronics Co Ltd
TW:3605
$797.94 Million
Quantum Corporation
NASDAQ:QMCO
$798.05 Million
Hang Xiao Steel Structure Co Ltd
SHG:600477
$797.39 Million
Center International Group Co Ltd
SHG:603098
$797.38 Million
Chongqing Road & Bridge Co Ltd
SHG:600106
$797.36 Million
Baramulti Suksessarana Tbk
JK:BSSR
$797.25 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Blue Sail Medical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 8,186,411,188 to 7,165,017,134, a change of -1,021,394,054 (-12.5%).
  • Net loss of 758,940,831 reduced equity.
  • Dividend payments of 168,383,838 reduced retained earnings.
  • Other comprehensive income increased equity by 272,425,955.
  • Other factors decreased equity by 366,495,341.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-758.94 Million -10.59%
Dividends Paid CN¥168.38 Million -2.35%
Other Comprehensive Income CN¥272.43 Million +3.8%
Other Changes CN¥-366.50 Million -5.12%
Total Change CN¥- -12.48%

Book Value vs Market Value Analysis

This analysis compares Blue Sail Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.76x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 24.89x to 0.76x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 CN¥0.22 CN¥5.41 x
2007-12-31 CN¥0.27 CN¥5.41 x
2008-12-31 CN¥0.44 CN¥5.41 x
2009-12-31 CN¥0.57 CN¥5.41 x
2010-12-31 CN¥2.02 CN¥5.41 x
2011-12-31 CN¥1.89 CN¥5.41 x
2012-12-31 CN¥2.00 CN¥5.41 x
2013-12-31 CN¥2.10 CN¥5.41 x
2014-12-31 CN¥2.20 CN¥5.41 x
2015-12-31 CN¥2.43 CN¥5.41 x
2016-12-31 CN¥2.65 CN¥5.41 x
2017-12-31 CN¥2.91 CN¥5.41 x
2018-12-31 CN¥10.57 CN¥5.41 x
2019-12-31 CN¥8.77 CN¥5.41 x
2020-12-31 CN¥9.66 CN¥5.41 x
2021-12-31 CN¥10.03 CN¥5.41 x
2022-12-31 CN¥10.49 CN¥5.41 x
2023-12-31 CN¥9.41 CN¥5.41 x
2024-12-31 CN¥8.08 CN¥5.41 x
2025-12-31 CN¥7.11 CN¥5.41 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Blue Sail Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -10.59%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -13.22%
  • • Asset Turnover: 0.34x
  • • Equity Multiplier: 2.34x
  • Recent ROE (-10.59%) is below the historical average (11.13%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 42.94% 9.43% 1.15x 3.95x CN¥25.96 Million
2007 31.80% 7.62% 1.56x 2.67x CN¥21.16 Million
2008 38.73% 11.88% 1.58x 2.07x CN¥45.52 Million
2009 29.44% 12.53% 1.26x 1.87x CN¥39.52 Million
2010 4.46% 6.49% 0.61x 1.13x CN¥-50.04 Million
2011 3.17% 3.11% 0.71x 1.43x CN¥-62.61 Million
2012 5.32% 3.84% 0.81x 1.71x CN¥-44.99 Million
2013 4.77% 3.52% 0.69x 1.96x CN¥-51.46 Million
2014 5.92% 4.02% 0.96x 1.54x CN¥-42.56 Million
2015 14.39% 11.28% 1.01x 1.27x CN¥51.95 Million
2016 13.94% 14.05% 0.81x 1.22x CN¥51.18 Million
2017 14.08% 12.75% 0.86x 1.29x CN¥58.25 Million
2018 4.45% 13.07% 0.21x 1.63x CN¥-433.12 Million
2019 5.81% 14.11% 0.26x 1.57x CN¥-352.94 Million
2020 17.91% 22.35% 0.46x 1.74x CN¥776.76 Million
2021 10.97% 14.25% 0.48x 1.61x CN¥102.08 Million
2022 -3.53% -7.60% 0.31x 1.50x CN¥-1.43 Billion
2023 -5.95% -11.54% 0.32x 1.64x CN¥-1.52 Billion
2024 -5.44% -7.13% 0.37x 2.05x CN¥-1.26 Billion
2025 -10.59% -13.22% 0.34x 2.34x CN¥-1.48 Billion

Industry Comparison

This section compares Blue Sail Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $1,609,955,576
  • Average return on equity (ROE) among peers: 8.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Blue Sail Medical Co Ltd (002382) CN¥9.41 Billion 42.94% 0.71x $797.66 Million
Beijing Centergate Technologies Holding Co Ltd (000931) $1.89 Billion 4.92% 0.86x $430.91 Million
Andon Health Co Ltd (002432) $608.95 Million -24.76% 0.35x $3.55 Billion
Allmed Medical Products Co Ltd Class A (002950) $2.75 Billion 15.67% 0.82x $761.72 Million
Guangzhou Improve Med Instrument (300030) $687.93 Million 5.45% 0.11x $276.44 Million
QITIAN Technology Group Co Ltd (300061) $64.46 Million 19.72% 1.76x $688.52 Million
Shanghai Tofflon Science Tech (300171) $3.00 Billion 7.82% 0.40x $1.51 Billion
Truking Technology Ltd (300358) $3.68 Billion 15.39% 1.70x $902.00 Million
Jiangxi Sanxin Medtec Co Ltd (300453) $250.27 Million 19.43% 0.52x $713.55 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573) $1.55 Billion 13.64% 0.15x $1.19 Billion

About Blue Sail Medical Co Ltd

SHE:002382 China Medical Instruments & Supplies
Market Cap
$797.66 Million
CN¥5.45 Billion CNY
Market Cap Rank
#9659 Global
#2411 in China
Share Price
CN¥5.41
Change (1 day)
-5.91%
52-Week Range
CN¥5.08 - CN¥8.66
All Time High
CN¥34.79
About

Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division, Cardiovascular and Cerebrovascular Business Unit, and Emergency Medical Services segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, and transcatheter aortic valve replacement systems; and he… Read more